PRTN3 and microscopic polyangiitis: This overlap in clinical presentations, combined with distinct genetic associations, [7], has prompted discussions on reclassifying AAV based on ANCA type (PR3 versus MPO) rather than clinical phenotypes (GPA versus MPA).